title: Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.
abstract: Cytolysis, interferon gamma and tumor necrosis factor (TNF) alpha secretion are major effector mechanisms of memory CD8+ T cells that are believed to be required for immunological protection in vivo. By using mutants of the intracellular bacterium Listeria monocytogenes, we found that none of these effector activities is sufficient to protect against secondary infection with wild-type (WT) bacteria. We demonstrated that CCL3 derived from reactivated memory CD8+ T cells is required for efficient killing of WT bacteria. CCL3 induces a rapid TNF-alpha secretion by innate inflammatory mononuclear phagocytic cells (MPCs), which further promotes the production of radical oxygen intermediates (ROIs) by both MPCs and neutrophils. ROI generation is the final bactericidal mechanism involved in L. monocytogenes clearance. These results therefore uncover two levels of regulation of the antibacterial secondary protective response: (a) an antigen-dependent phase in which memory CD8+ T cells are reactivated and control the activation of the innate immune system, and (b) an antigen-independent phase in which the MPCs coordinate innate immunity and promote the bactericidal effector activities. In this context, CCL3-secreting memory CD8+ T cells are able to mediate "bystander" killing of an unrelated pathogen upon antigen-specific reactivation, a mechanism that may be important for the design of therapeutic vaccines.
authors: Institut National de la Santé et de la Recherche Médicale E-344, Groupe Avenir, Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Valbonne, France.
authors: Emilie
authors: E
authors: Narni-Mancinelli
authors: Laura
authors: L
authors: Campisi
authors: Delphine
authors: D
authors: Bassand
authors: Julie
authors: J
authors: Cazareth
authors: Pierre
authors: P
authors: Gounon
authors: Nicolas
authors: N
authors: Glaichenhaus
authors: Grégoire
authors: G
authors: Lauvau
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000378:metabolism; D024201:Bystander Effect / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology / Q000469:parasitology; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D019742:Chemokines, CC / Q000276:immunology* / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D005260:Female; D007109:Immunity / Q000276:immunology*; D007114:Immunization; D007156:Immunologic Memory / Q000276:immunology*; D007371:Interferon-gamma / Q000378:metabolism; D018320:Leishmania major / Q000276:immunology; D008089:Listeria monocytogenes / Q000276:immunology*; D008088:Listeriosis / Q000276:immunology; D019402:Macrophage Inflammatory Proteins / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D018448:Models, Immunological; D009154:Mutation / Q000235:genetics; D009504:Neutrophils / Q000378:metabolism; D010586:Phagocytes / Q000276:immunology* / Q000382:microbiology; D017382:Reactive Oxygen Species; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D048069:Tumor Necrosis Factors / Q000276:immunology*
chemical_list: D001426:Bacterial Proteins; C496534:Ccl3 protein, mouse; D054405:Chemokine CCL3; D054407:Chemokine CCL4; D019742:Chemokines, CC; D019402:Macrophage Inflammatory Proteins; D017382:Reactive Oxygen Species; D014409:Tumor Necrosis Factor-alpha; D048069:Tumor Necrosis Factors; D007371:Interferon-gamma
references: J Immunol. 2000 Jun 15;164(12):6444-52
references: 10843700
references: J Exp Med. 1989 Aug 1;170(2):589-94
references: 2502601
references: Nature. 1999 Oct 14;401(6754):708-12
references: 10537110
references: Science. 2000 Nov 17;290(5495):1354-8
references: 11082062
references: Nat Immunol. 2003 Dec;4(12):1191-8
references: 14625547
references: Eur J Immunol. 2006 Jun;36(6):1453-64
references: 16637009
references: J Immunol. 1998 Jan 15;160(2):898-905
references: 9551927
references: Nature. 2006 Apr 13;440(7086):944-8
references: 16612386
references: Nat Immunol. 2000 Oct;1(4):311-6
references: 11017102
references: J Exp Med. 2001 Aug 6;194(3):343-54
references: 11489953
references: FEBS Lett. 2003 Sep 25;552(2-3):110-4
references: 14527670
references: Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8115-9
references: 7667254
references: Infect Immun. 2000 Aug;68(8):4470-6
references: 10899844
references: J Exp Med. 1998 Jan 5;187(1):1-14
references: 9419206
references: J Exp Med. 1995 Sep 1;182(3):751-8
references: 7650482
references: Cell Microbiol. 2007 Jun;9(6):1445-54
references: 17244189
references: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5610-5
references: 15044705
references: J Immunol. 2014 Oct 1;193(7):3185-221
references: 25240017
references: Infect Immun. 1996 Apr;64(4):1197-202
references: 8606078
references: J Immunol. 1992 May 1;148(9):2764-9
references: 1573267
references: J Immunol. 1999 May 1;162(9):5423-8
references: 10228020
references: Science. 2001 Nov 23;294(5547):1735-9
references: 11721060
references: J Immunol Methods. 2003 Oct 1;281(1-2):65-78
references: 14580882
references: Annu Rev Immunol. 2005;23:307-36
references: 15771573
references: J Exp Med. 1996 Oct 1;184(4):1397-411
references: 8879212
references: J Immunol. 1987 Apr 1;138(7):2266-71
references: 3104455
references: Immunity. 1999 Jan;10(1):29-38
references: 10023768
references: Nature. 2006 Apr 13;440(7086):890-5
references: 16612374
references: J Clin Invest. 2006 Jul;116(7):2033-43
references: 16778989
references: Science. 1992 Apr 10;256(5054):225-8
references: 1373522
references: J Immunol. 2003 Oct 15;171(8):4254-62
references: 14530349
references: Immunity. 2005 Jan;22(1):93-104
references: 15664162
references: Immunity. 1998 Mar;8(3):353-62
references: 9529152
references: Science. 1995 Sep 15;269(5230):1583-5
references: 7667639
references: Nature. 1982 May 20;297(5863):233-4
references: 6176874
references: J Immunol. 1982 Jul;129(1):351-7
references: 6282967
references: Int J Biochem Cell Biol. 2004 Oct;36(10):1882-6
references: 15203102
references: Int Immunol. 1992 Dec;4(12):1413-8
references: 1286064
references: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6181-6
references: 11972057
references: Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12432-7
references: 14527997
references: Cell. 1992 Feb 7;68(3):521-31
references: 1739966
references: J Immunol. 2000 Jul 1;165(1):5-9
references: 10861027
references: Annu Rev Immunol. 2000;18:275-308
references: 10837060
references: Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8093-8
references: 9223320
references: J Cell Biol. 2007 Apr 9;177(1):7-11
references: 17420288
references: Eur J Immunol. 1999 Oct;29(10):3089-97
references: 10540319
references: Infect Immun. 1998 Sep;66(9):4143-50
references: 9712760
references: J Exp Med. 2004 Aug 2;200(3):367-76
references: 15289505
references: Immunology. 1995 Oct;86(2):256-62
references: 7490127
references: Blood. 2000 Jul 15;96(2):719-26
references: 10887140
references: Immunity. 1995 Jul;3(1):109-17
references: 7621071
references: Immunity. 1997 Sep;7(3):419-32
references: 9324362
references: Eur J Immunol. 2006 Nov;36(11):3060-70
references: 17048270
references: Immunity. 2003 Dec;19(6):891-901
references: 14670305